Second, dipeptidyl peptidase-4 (DPP4) enzyme, a common pharmacological target for type 2 diabetes, was also a functional coronavirus receptor (Raj et al., 2013), which might be another potential mechanism that explains the link between COVID-19 and DM. The gene discussed is DPP4; the disease is COVID-19.